David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

CHICAGO—On the heels of his 2025 State of the State budget address, Governor Pritzker focused on one of his top legislative ...

House Democrats beat back a series of Republican amendments on party-line votes Wednesday, setting up a final vote on a ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to lower drug prices. But some lawmakers have questioned if thats really the ...

WASHINGTON, DC - OCTOBER 06: Activists protest the price of prescription drug costs in front of the ... [+] U.S. Department of Health and Human Services (HHS) building Your father’s rheumatoid ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...